enow.com Web Search

  1. Ad

    related to: axonal polyneuropathy treatment guidelines
    • Sign Up

      Get updates about ATTR

      Complete the form to get more info

    • Diagnosing ATTR

      Get familiar with the tests

      Know how you can help your doctor

Search results

  1. Results from the WOW.Com Content Network
  2. Polyneuropathy - Wikipedia

    en.wikipedia.org/wiki/Polyneuropathy

    According to Lopate, et al., methylprednisolone is a viable treatment for chronic inflammatory demyelinative polyneuropathy (which can also be treated with intravenous immunoglobulin). The authors also indicate that prednisone has greater adverse effects in such treatment, as opposed to intermittent (high-doses) of the aforementioned medication.

  3. Acute motor axonal neuropathy - Wikipedia

    en.wikipedia.org/wiki/Acute_motor_axonal_neuropathy

    Acute motor axonal neuropathy (AMAN) is a variant of Guillain–Barré syndrome. It is characterized by acute paralysis and loss of reflexes without sensory loss. Pathologically , there is motor axonal degeneration with antibody-mediated attacks of motor nerves and nodes of Ranvier .

  4. Peripheral neuropathy - Wikipedia

    en.wikipedia.org/wiki/Peripheral_neuropathy

    Peripheral neuropathy may be classified according to the number and distribution of nerves affected (mononeuropathy, mononeuritis multiplex, or polyneuropathy), the type of nerve fiber predominantly affected (motor, sensory, autonomic), or the process affecting the nerves; e.g., inflammation (), compression (compression neuropathy), chemotherapy (chemotherapy-induced peripheral neuropathy).

  5. Hereditary neuropathy with liability to pressure palsy

    en.wikipedia.org/wiki/Hereditary_neuropathy_with...

    Hereditary neuropathy with liability to pressure palsy (HNPP) is a peripheral neuropathy, a condition that affects the nerves. [4] Pressure on the nerves can cause tingling sensations, numbness, pain, weakness, muscle atrophy and even paralysis of the affected area. In normal individuals, these symptoms disappear quickly, but in sufferers of ...

  6. Hereditary motor and sensory neuropathy - Wikipedia

    en.wikipedia.org/wiki/Hereditary_motor_and...

    There is currently no known pharmacological treatment to hereditary motor and sensory neuropathy. However, the majority of people with these diseases are able to walk and be self-sufficient. [3] Some methods of relief for the disease include physical therapy, stretching, braces, and sometimes orthopedic surgery.

  7. Critical illness polyneuropathy - Wikipedia

    en.wikipedia.org/.../Critical_illness_polyneuropathy

    Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are overlapping syndromes of diffuse, symmetric, flaccid muscle weakness occurring in critically ill patients and involving all extremities and the diaphragm with relative sparing of the cranial nerves.

  8. Sensory neuronopathy - Wikipedia

    en.wikipedia.org/wiki/Sensory_neuronopathy

    Sensory neuronopathy differs from the more common length dependent axonal polyneuropathies (such as diabetic sensorimotor polyneuropathy) in that the symptoms do not progress in a distal to proximal pattern (starting in the feet and progressing to the legs and hands), rather symptoms develop in a multifocal, asymmetric, and non-length dependent ...

  9. Familial amyloid polyneuropathy - Wikipedia

    en.wikipedia.org/.../Familial_amyloid_polyneuropathy

    In May 2019, the FDA approved two tafamidis preparations for the treatment of transthyretin-mediated cardiomyopathy, but has not approved it for the treatment of transthyretin familial amyloid polyneuropathy. [15] In August 2018, the FDA approved patisiran, an siRNA-based treatment, at an expected cost of up to $450,000 per year. [16]

  1. Ad

    related to: axonal polyneuropathy treatment guidelines